A new treatment is available at WVU Medicine Princeton Community Hospital for people dealing with arthritis pain. According ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in ...

You usually have radiotherapy to treat cancer that started in the back passage (rectum). It is not normally a treatment for cancer of the large bowel (colon). You might have external or internal beam ...

Chennai: Deficiencies in planning and a critical lack of synchronised efforts resulted in significant delays in the purchase, ...

The role of radiosurgery in the treatment of grade 2 meningioma remains unclear. This study aimed to evaluate the long-term outcomes of gamma knife radiosurgery (GKRS) in patients with grade 2 ...

At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integration of MapRT with RayStation®* ...

Prostate cancer is the most common cancer in men worldwide. Thanks to scientific breakthroughs, there are more ways than ever to treat it — especially when it’s caught early. One ...

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

The global intraoperative radiation therapy systems market is poised for significant growth, with projections indicating a substantial increase in value over the next decade. According to recent ...